Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
suppression and immunotherapy resistance in hepatocellular carcinoma (HCC), the third leading cause of cancer-related death worldwide. This Cancer Research UK Career Establishment Award funded project will use
-
Abramson Cancer Center seek a highly organized and proactive Research Administrative Coordinator to support a dynamic translational research environment in cancer immunotherapy. This position provides
-
have identified its expression also in immuno-suppressive macrophages. Inhibition of ALK1 improves the efficacy of immunotherapy as a result of profound alterations in the immune cell landscape. Here, we
-
, and cellular immunotherapy. Our Hematologic Malignancy/BMT/Cell Therapy group is a charter Core Center of the Blood and Marrow Transplant Clinical Trials Network for 20 years, has been FACT-accredited
-
immunotherapy. Possible project elements include: Artificial cells that process cytokine signals or re-establish tissue homeostasis Synthetic signaling hubs for tumor-microenvironment models Reporter cell assays
-
Bose, Dr Ian Sudbery Application Deadline: 17 July 2026 Details Muscle invasive bladder cancer can be classified into gene expression subtypes that can help guide chemo- and immunotherapy choices
-
the project entitled “Spatial determinants of immunotherapy resistance in cancer”, funded by the NCN (National Science Centre) in cooperation with the SNSF (Swiss National Science Foundation). Our laboratory
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 22 days ago
Children’s Allergy and Immunology Raleigh Clinic. Specific emphasis is placed on providing cutting edge diagnostic and treatment options for food allergy, asthma, and allergen immunotherapy leveraging
-
Posting Summary Rutgers, The State University of New Jersey is seeking a Postdoctoral Associate in Cancer Immunotherapy within the Department of Medical Immunology at the Rutgers Cancer Institute. A
-
Científica AECC- RETOS245779LLOV,“Neoadjuvant-adjuvant immunotherapy and cancer vaccines to improve survival in hepatocellular carcinomaNeoadjuvant-adjuvant immunotherapy and cancer vaccines to improve